Propranolol and depression: a reevaluation based on a pilot clinical trial

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Propranolol, a beta-adrenergic blocking agent, is associated with various neuropsychiatric side effects.
• Depression is frequently cited as a rare side effect of propranolol, particularly with long-term, high-dose use.

Purpose of the Study:

• To critically evaluate the evidence linking propranolol use to clinically significant mood disturbances, specifically depression.
• To assess the validity of existing claims attributing depressogenic effects to propranolol.

Main Methods:

• Review of existing literature, including clinical studies and case reports.
• Analysis of the quality and methodology of studies linking propranolol to depression.

Main Results:

• A paucity of robust evidence directly links propranolol to clinically significant depression.
• Key supporting references are often based on retrospective, uncontrolled studies lacking standardized depression assessments.
• Much of the evidence relies on scattered case reports, which are difficult to interpret given the prevalence of depression and its cyclical nature.

Conclusions:

• The direct causal role of propranolol in inducing depression is debatable and not well-supported by high-quality scientific evidence.
• The attribution of depression as a side effect of propranolol may be overstated.
• Further rigorous research is needed to clarify any potential link between propranolol and mood disturbances.